Moreover, reduced SLC22A7 expression in the liver could indicate a significant risk of HCC development in chronic hepatitis C, which was independent of other risk factors as described by Yasui et al. (43). The gene discussed is SLC22A7; the disease is hepatocellular carcinoma.